US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,476.68

-3.3748-0.23%

Number of Gainers:4

Number of Losers:15

Number of Flat:1

PE:- -

High:1,493.87

Open:1,479.95

Low:1,472.49

Close:1,480.06

Loading ...

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern

Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial

Simply Wall St.

Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ

Is Pfizer Inc. (PFE) the Best Retirement Stock to Buy According to Hedge Funds?

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award

Is Pfizer Inc. (PFE) the Best Stock Under $50 to Buy Right Now?

Moderna Shares Down 7.1% After Report Trump Administration Weighs Pulling Funding for Co's Bird Flu Vaccine

THOMSON REUTERS

CVS Pharmacy® introduces enhanced flu testing and treatment offerings

Novavax Shares up 13.3% After Quarterly Loss Shrinks

THOMSON REUTERS

BUZZ-Novavax rises after narrower quarterly loss

Urgent Crypto Alert: Ethereum Price Plummets 7% Amidst Market Sell-Off; Is Bitcoin Holding?

Aptos (APT) Holds Strong at Key Support as ETF Interest Grows

Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate Ocu410st for Stargardt Disease

THOMSON REUTERS

Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease

Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1476.6809,"timestamp":1741636799999,"preClose":1480.0557,"halted":0,"volume":122558961,"delay":0,"changeRate":-0.00228,"change":-3.374756,"pbRate":4.037358,"amount":7780388666.560105,"amplitude":0.01444,"prevYearClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"turnoverRate":0.007925,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1493.8654,"amplitude":0.01444,"preClose":1480.0557,"low":1472.4934,"pbRate":"4.037358","latestPrice":1476.6809,"volume":122558961,"delay":0,"open":1479.9548,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"sixtyDayClose":1302.6017,"secType":"PLATE","market":"US","turnoverRate":0.007925,"peRate":31.999995,"marketCap":1217033329494.5,"floatMarketCap":1195717640124.5,"timestamp":1741636799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":15,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514331728","title":"GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331728","media":"NewMediaWire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514331728?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:22","pubTimestamp":1740684136,"startTime":"0","endTime":"0","summary":"GeoVax Advancing GEO-MVA Vaccine Candidate to Bolster Global Supply Options. ATLANTA, GA - February 27, 2025  - GeoVax Labs, Inc.  commented on today's statement from The World Health Organization  concerning Mpox. In its statement the WHO reaffirmed the severity of the ongoing Mpox epidemic, issuing its third declaration within six months of Mpox as a Public Health Emergency of International Concern . This follows the initial declaration on August 14, 2024, and the second on November 22, 2024, underscoring the persistent and escalating nature of the outbreak.GEO-MVA, in conjunction with the GeoVax development program of implementing an advanced manufacturing process for MVA vaccines, may offer several key advantages to complement and potentially strengthen the global Mpox response:. Expanded manufacturing capacity at lower cost - The advanced MVA manufacturing process is directed towards establishing a higher yield, increased production capability with lower production costs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-response-whos-third-declaration-192216075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","R","BK4568","GOVX","GOVXW","BK4548","BK4139","BK4022","BK4585","BK4588","BK4232","BK4551","BK4535"],"gpt_icon":1},{"id":"2514363253","title":"Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514363253","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514363253?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:04","pubTimestamp":1740683057,"startTime":"0","endTime":"0","summary":"Invivyd (NasdaqGM:IVVD) experienced a significant 198% price increase over the past month, likely driven by the release of positive clinical data for its novel monoclonal antibody candidate, VYD2311. The promising results from the Phase 1/2 trial revealed improved safety and enhanced antiviral potency, positioning the company as a potential leader in COVID-19 treatment alternatives. This advancement coincides with a mixed performance in the broader U.S. stock market, where major indices...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/invivyd-nasdaqgmivvd-surges-198-after-positive-results-from","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4548","BK4585","IVVD","BNTX","BK4139","BK4588","BK4568","BK4551"],"gpt_icon":1},{"id":"2514339412","title":"Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2514339412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514339412?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:02","pubTimestamp":1740682920,"startTime":"0","endTime":"0","summary":"Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company's $590 million contract to help develop a bird-flu vaccine.Moderna was awarded the contract from the U.S. Department of Health and Human Services in January during the Biden administration to accelerate development of its mRNA-based vaccine, and as part of an effort to address growing concerns of a bird flu pandemic in humans.The Trump administration is currently reviewing the contract, according to a person familiar with the matter.\"While it is crucial that the U.S. Department and Health and Human Services support pandemic preparedness, four years of the Biden administration's failed oversight have made it necessary to review agreements for vaccine production,\" an HHS spokesman said.A bird-flu outbreak has plagued American farmers, infecting commercial and backyard poultry folks that has contributed to sky-high egg prices and dozens of people getting sick.Vaxart, anothe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","BK4585","BK4588","BK4532","BK4501","BK4534","MRNA","BK4533","BK4568","BK4548","HHS","BK4139","BK4551"],"gpt_icon":1},{"id":"2514336768","title":"Is Pfizer Inc. (PFE) the Best Retirement Stock to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336768","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514336768?lang=en_us&edition=fundamental","pubTime":"2025-02-28 02:16","pubTimestamp":1740680204,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc.  stands against other best retirement stocks to buy according to hedge funds.According to the Census Bureau, the 65-and-older population in the United States will grow from 58 million in 2022 to 82 million by 2050, when it is expected to account for more than a quarter of the total population. The World Economic Forum further predicts that half of kids born in the United States in 2007 would survive to the age of 103. As such, wages seem to be falling behind inflation as people live longer lives. That’s especially true now that businesses have moved the burden of retirement savings to employees, giving 401s instead of pensions that promise a fixed income each month.Conversely, Doonan believes that a more streamlined network of retirement schemes across the country can help private-sector companies reduce employee turnover. In addit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-inc-pfe-best-retirement-181644200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234572021.USD","US7Y.BOND","IE00B19Z3B42.SGD","US2Y.BOND","IE0002270589.USD","LU0170899867.USD","LU0321505868.SGD","BK4534","LU1883839398.USD","BK4533","LU0225284248.USD","LU1894683348.USD","LU1057294990.SGD","BK4588","LU0306806265.USD","US3Y.BOND","LU1023059063.AUD","SG9999013999.USD","US30Y.BOND","IE000M9KFDE8.USD","LU0122379950.USD","LU0321505439.SGD","US5Y.BOND","SGXZ57979304.SGD","BK4585","LU0456855351.SGD","SG9999001176.SGD","US10Y.BOND","SG9999002232.USD","US6M.BOND","SG9999011175.SGD","BK4592","LU0225771236.USD","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","BK4599","US12M.BOND","LU0985481810.HKD","BK4007","BK4581","PFE","LU0306807586.USD","SG9999001176.USD","LU1066051498.USD","LU0058720904.USD","SG9999002224.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","BK4550"],"gpt_icon":1},{"id":"2514138209","title":"Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138209","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514138209?lang=en_us&edition=fundamental","pubTime":"2025-02-28 00:24","pubTimestamp":1740673450,"startTime":"0","endTime":"0","summary":"Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships and expects up to $350 million in 2025 revenue.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/02/44013531/novavax-reports-smaller-q4-loss-shifts-focus-from-commercializing-covid-19-vaccine-to-maximize-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4007","BK4585","BNTX","IE00BFXG1179.USD","BK4139","BK4588","SNY","BK4568","BK4547"],"gpt_icon":0},{"id":"2514382522","title":"Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382522","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514382522?lang=en_us&edition=fundamental","pubTime":"2025-02-28 00:08","pubTimestamp":1740672480,"startTime":"0","endTime":"0","summary":"Trump administration is reviewing a contract extended to Moderna in final days of the Biden administration, Bloomberg reported. Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu vaccine.The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. Moderna  won the $590 million contract in the final days of Biden's presidency to use its mRNA vaccine technology for a bird-flu vaccine.The U.S. is currently in the midst of a bird-flu outbreak that has led to the culling of poultry flocks, has sent egg prices soaring and has infected cattle - along with several humans.Read also: Egg prices are surging again. Why Powell and the Fed's grip on inflation may be slipping.Moderna's mRNA technology was behind its COVID-19 vaccine, which was the company's first product to win Food and Drug Administration approval. The company h","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4532","BK4501","BK4568","BK4585","BK4551","BK4009","BK4588","BK4139","MRNA","BK4533","HHS","BK4534"],"gpt_icon":1},{"id":"2514389049","title":"Is Pfizer Inc. (PFE) the Best Stock Under $50 to Buy Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389049","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389049?lang=en_us&edition=fundamental","pubTime":"2025-02-27 23:16","pubTimestamp":1740669365,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now.In this article, we are going to take a look at where Pfizer Inc.  stands against the other stocks.Inflation expectations have also risen, with the one-year projected inflation rate for US consumers rising to 4.3% in February from 3.3% in January. This increase in inflation expectations, along with a slowing economy, has sparked fears about stagflation, which is characterized as stalled growth and rising prices. According to a Bank of America poll of global fund managers published on February 18, the number of investors expecting stagflation in the coming year has hit a seven-month high. At the same time, investors remained bullish on stocks, perceiving a trade war as a low-probability risk.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-inc-pfe-best-stock-151605272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1057294990.SGD","LU1023059063.AUD","SG9999002232.USD","BK4592","LU0456855351.SGD","BK4581","LU0234572021.USD","LU0868494617.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU0225284248.USD","COMP","LU0306807586.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","BK4550","BK4588","LU0289739699.SGD","LU0058720904.USD","LU1894683264.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU0122379950.USD","LU0321505439.SGD","BK4585","IE00BLSP4452.SGD","BK4568","PFE","IE00BLSP4239.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4534","BK4533","BK4599","LU0321505868.SGD","SG9999013999.USD","SG9999001176.SGD","BK4007","LU1883839398.USD","IE00B19Z3581.USD","IE0002270589.USD","SG9999002224.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2514385229","title":"Moderna Shares Down 7.1% After Report Trump Administration Weighs Pulling Funding for Co's Bird Flu Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385229?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:51","pubTimestamp":1740667881,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI1ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","BK4139","BK4501","BK4534","BK4551","BK4568","BK4548","BK4588","BK4532","BK4585","BK4533"],"gpt_icon":0},{"id":"2514389263","title":"CVS Pharmacy® introduces enhanced flu testing and treatment offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389263","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389263?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:45","pubTimestamp":1740667500,"startTime":"0","endTime":"0","summary":"As flu cases continue to remain high, select CVS pharmacies across 37 states launch combo test for Flu A, Flu B and COVID-19. Pharmacists can also prescribe flu treatment for eligible patients in 13 states with positive test results helping ensure timely access to care. \"Timely access to care and treatment is critical with illnesses like influenza and COVID-19,\" said Jinali Desai, PharmD, MBA, MPH, Vice President, Pharmacy Health Services for CVS Health. \"CVS Pharmacy's array of testing and treatment options allows us to be with our patients every step of the way. From immunizations to symptom evaluation to prescribing medications for those who are eligible, our trusted pharmacists offer convenient and accessible care when patients need us most.\". A pharmacy-administered flu and COVID-19 test costs $29.99. The pharmacist assessment will cost $45, regardless of whether medication is prescribed. Patients may use HSA or FSA funds to cover the assessment fee. Any cost or copay for a prescr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cvs-pharmacy-introduces-enhanced-flu-144500208.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvs-pharmacy-introduces-enhanced-flu-144500208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765489.SGD","BK4139","LU0070302665.USD","LU0006061336.USD","CVS","BK4548","IE00BSNM7G36.USD","BK4585","BK4568","LU1571399168.USD","BK4504","BK4535","LU0061475181.USD","BNTX","IE00BZ1G4Q59.USD","LU0211331839.USD","IE00BKVL7J92.USD","BK4196","LU0208291251.USD","LU1059921491.USD","LU0162691827.USD","LU0072461881.USD","BK4581","BK4551","LU1699723380.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2514839183","title":"Novavax Shares up 13.3% After Quarterly Loss Shrinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839183?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:33","pubTimestamp":1740666796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI1G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4568","BK4547","BK4585","BK4139","NVAX"],"gpt_icon":0},{"id":"2514800107","title":"BUZZ-Novavax rises after narrower quarterly loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514800107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514800107?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:04","pubTimestamp":1740665072,"startTime":"0","endTime":"0","summary":"BUZZ-Novavax rises after narrower quarterly loss ** Shares of Maryland-based vaccine maker Novavax NVAX.O up 1.6% at $7.44 premarket** Company posts Q4 adj loss of 51 cents per share vs adj loss of $1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4139","BK4568","BK4547","BK4588","BK4585"],"gpt_icon":0},{"id":"2514009828","title":"Urgent Crypto Alert: Ethereum Price Plummets 7% Amidst Market Sell-Off; Is Bitcoin Holding?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514009828","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514009828?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:54","pubTimestamp":1740664464,"startTime":"0","endTime":"0","summary":"The cryptocurrency market is experiencing another bout of volatility as a widespread sell-off grips the digital asset space. Ethereum , the second-largest cryptocurrency, is feeling the heat intensely, plunging a significant 7% in the last 24 hours. Meanwhile, Bitcoin , the king of crypto, is navigating turbulent waters, briefly dipping but managing to stay afloat above the critical $86,000 mark, according to CoinDesk data. Let’s dive into what’s fueling this market turbulence and what it means for your crypto portfolio.Decoding the Crypto Sell-Off: What’s Behind the Market Decline?Global Macroeconomic Uncertainty: Just like traditional financial markets, the cryptocurrency market is increasingly sensitive to macroeconomic signals. Concerns about inflation, rising interest rates, and potential recession are weighing heavily on investor sentiment.Broader Altcoin Volatility: Altcoins, including Ethereum, generally tend to be more volatile than Bitcoin. During market downturns, investors ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c06e916f86cc14b63255e8/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4225","BK4086","BK4203","CETH","BTC","BK4585","ETH.USD.HKCC","TON.USD.CC","BTC.USD.CC","BK4550","FETH","BK4588","LTC","LTC.USD.CC","BTC.USD.HKCC","ETHV","LTC.USD.HKCC","BK4601","ETH","APT","LDO.USD.HKCC","APT.USD.CC","EZET","TON.USD.HKCC","QETH","FDN","APT.USD.HKCC","BK4568","BK4594","ETH.USD.CC"],"gpt_icon":1},{"id":"2514009698","title":"Aptos (APT) Holds Strong at Key Support as ETF Interest Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2514009698","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514009698?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:54","pubTimestamp":1740664464,"startTime":"0","endTime":"0","summary":"APT remains above its critical $5.21 support level, showing resilience and signaling potential bullish movement despite recent market declines.Institutional demand strengthens as the BITWISE APTOS ETF is registered in Delaware, alongside existing European Aptos exchange-traded products.The oversold Stochastic RSI at 3.58 suggests a short-term price bounce, with further confirmation needed from rising volume and RSI improvement.The APT cryptocurrency traded above a high-timeframe level, reflecting its strength in a generally volatile market. Recent price moves are hinting at a reversal scenario with buyers monitoring key points in expectation of bullish sentiment.If APT remains above $5.21, a bounce towards $7.50 and $10.00 can be expected in a matter of a couple of weeks. A drop below that level will cause a protracted fall. The oversold Stochastic RSI is a warning that a bounce is near, though rising trading activity and a break above 50 on the RSI are required before a confirmed boun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c06e916f86cc14b63255ec/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["APT.USD.HKCC","BK4550","BK4086","BK4585","FDN","APT","RSI","BK4150","BK4588","BK4568","APT.USD.CC"],"gpt_icon":0},{"id":"2514807148","title":"Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate Ocu410st for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2514807148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514807148?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:46","pubTimestamp":1740664010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA6SCFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":0},{"id":"2514991800","title":"Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2514991800","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514991800?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:46","pubTimestamp":1740663960,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Feb.  27, 2025  (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced thata","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033879/0/en/Ocugen-Inc-Announces-FDA-Alignment-on-Phase-2-3-Pivotal-Confirmatory-Clinical-Trial-for-Modifier-Gene-Therapy-Candidate-OCU410ST-for-Stargardt-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":1},{"id":"2514880823","title":"Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2514880823","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514880823?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:38","pubTimestamp":1740663513,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson  stands against the other best vaccine stocks to buy now.What Will Trump’s Tariffs Mean for the Pharma Industry?On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay on their implementation. When asked about the postponed tariffs at a White House press conference, President Trump said:. “The tariffs are going forward on time, on schedule.”He claimed that foreign nations have been taking advantage of the US in “just about everything,” reiterating his plans to impose “reciprocal tariffs.”“So the tariffs will go forward, yes, and we’re going to make up a lot of territory,” Trump said.We recently discussed what Trump’s tariffs could mean for the healthcare","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-one-best-133833643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002141913.USD","LU1057294990.SGD","LU2112291526.USD","LU2129689514.USD","LU1244550221.USD","BK4504","LU0912757837.SGD","LU1032955483.USD","LU0320765646.SGD","LU2347655156.SGD","LU1221951046.USD","IE00BDGV0183.EUR","LU0058720904.USD","LU0640476718.USD","JNJ","LU1585245621.USD","IE00B3PB1722.GBP","LU1929549753.HKD","BK4568","LU0882574055.USD","IE00BSNM7G36.USD","BK4559","LU1023059063.AUD","LU0114720955.EUR","LU0345769128.USD","LU1066051811.HKD","LU1267930813.SGD","LU2129689605.HKD","IE0002270589.USD","BK4550","LU2133065610.SGD","LU0345769631.USD","BK4534","LU1506573853.SGD","LU2430703251.USD","LU0795875086.SGD","LU0234572021.USD","LU2089984988.USD","LU0122379950.USD","LU1261432733.SGD","IE00BJT1NW94.SGD","BK4007","LU0098860793.USD","LU2592432038.USD","LU0289739699.SGD","BK4588","IE00BJJMRZ35.SGD","LU1059921491.USD","LU2468319806.SGD","SG9999002224.SGD"],"gpt_icon":0}],"pageSize":16,"totalPage":19,"pageCount":15,"totalSize":300}]}}